{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:50:41Z","timestamp":1791651041572,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005780","name":"Chitkara University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.brainres.2025.149568","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:30:51Z","timestamp":1741955451000},"page":"149568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential"],"prefix":"10.1016","volume":"1855","author":[{"given":"Jashanpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2025.149568_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2019.12.003","article-title":"An emerging interplay between extracellular vesicles and cytokines","volume":"51","author":"Aiello","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.brainres.2025.149568_b0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1381612822666151125000300","article-title":"Inflammatory process in Alzheimer\u2019s and Parkinson\u2019s diseases: central role of cytokines","volume":"22","author":"Alam","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0015","article-title":"Neuroprotective function of DJ\u20101 in Parkinson\u2019s disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"10.1016\/j.brainres.2025.149568_b0020","series-title":"Disease-Modifying Targets in Neurodegenerative Disorders: Paving the Way for Disease-Modifying Therapies","year":"2017"},{"key":"10.1016\/j.brainres.2025.149568_b0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2025.149568_b0030","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.3390\/cells10123547","article-title":"Autophagy-lysosomal pathway as potential therapeutic target in Parkinson\u2019s disease","volume":"10","author":"Bonam","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.brainres.2025.149568_b0035","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2025.149568_b0040","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.3390\/ijms252313049","article-title":"Amyloid-\u03b2, \u03b1-synuclein and prion protein implicated in Alzheimer\u2019s disease, Parkinson\u2019s disease and prionopathies","volume":"25","author":"Cehlar","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149568_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchemneu.2017.12.004","article-title":"Reinforcing mitochondrial functions in aging brain: an insight into Parkinson\u2019s disease therapeutics","volume":"95","author":"Chandra","year":"2019","journal-title":"J. Chem. Neuroanatomy"},{"issue":"5","key":"10.1016\/j.brainres.2025.149568_b0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","article-title":"Neuroinflammation in parkinson\u2019s disease and its treatment opportunities","volume":"39","author":"\u00c7\u0131nar","year":"2022","journal-title":"Balkan Med. J."},{"issue":"2","key":"10.1016\/j.brainres.2025.149568_b0055","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/mmr.2015.4657","article-title":"Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt\/Nrf2 pathway","volume":"13","author":"Cui","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-024-05419-5","article-title":"Lysosomal dysfunction in \u03b1-synuclein pathology: molecular mechanisms and therapeutic strategies","volume":"81","author":"Dai","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.brainres.2025.149568_b0065","doi-asserted-by":"crossref","unstructured":"Dewangan, B., Kumar, K., Kumar, A., Bodhe, P.R., Beni, S., Sahu, B. (2023). Metal Chelators as a Potential Therapeutic Agent for Alzheimer\u2019s Disease. In Natural Product-based Synthetic Drug Molecules in Alzheimer\u2019s Disease: Therapeutic & Theranostic Agents (pp. 347-374). Singapore: Springer Nature Singapore.","DOI":"10.1007\/978-981-99-6038-5_13"},{"issue":"18","key":"10.1016\/j.brainres.2025.149568_b0070","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3390\/nu14183709","article-title":"Recent advances in the neuroprotective properties of ferulic acid in Alzheimer\u2019s disease: a narrative review","volume":"14","author":"Di Giacomo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.brainres.2025.149568_b0075","first-page":"357","article-title":"TGF-\u03b2 and neuronal survival in neurodegeneration","volume":"13","author":"Diniz","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2025.149568_b0080","first-page":"284","article-title":"TGF-\u03b2 in neuroprotection","volume":"98","author":"Dobolyi","year":"2012","journal-title":"Prog. Chem. Org. Nat. Prod. Neurobiol."},{"key":"10.1016\/j.brainres.2025.149568_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","article-title":"Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease","volume":"51","author":"Dolgacheva","year":"2019","journal-title":"J. Bioenerget. Biomembranes"},{"key":"10.1016\/j.brainres.2025.149568_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2025.149568_b0095","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease","volume":"13","author":"Emin","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.brainres.2025.149568_b0100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0105","article-title":"Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF","volume":"2015","author":"Fischer","year":"2015","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"10.1016\/j.brainres.2025.149568_b0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.26624","article-title":"Oligomeropathies and Pathogenesis of Alzheimer and Parkinson\u2019s Diseases","volume":"31","author":"Forloni","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1016\/j.brainres.2025.149568_b0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress, and mitochondrial dysfunction: cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease","author":"Ganguly","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"6","key":"10.1016\/j.brainres.2025.149568_b0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tips.2012.03.008","article-title":"NADPH oxidases: novel therapeutic targets for neurodegenerative diseases","volume":"33","author":"Gao","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.brainres.2025.149568_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/brainsci6020019","article-title":"Impact of increased astrocyte expression of IL-6, CCL2 or CXCL10 in transgenic mice on hippocampal synaptic function","volume":"6","author":"Gruol","year":"2016","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0130","first-page":"1817","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease","volume":"41","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.brainres.2025.149568_b0135","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3390\/biomedicines10071743","article-title":"Synaptic disruption by soluble oligomers in patients with Alzheimer\u2019s and Parkinson\u2019s disease","volume":"10","author":"Gutierrez","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0140","first-page":"726","article-title":"TNF-\u03b1 exacerbates glutamate excitotoxicity in neurodegeneration","volume":"60","author":"Harms","year":"2012","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.brainres.2025.149568_b0145","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.jmb.2015.02.002","article-title":"A first line of stress defense: small heat shock proteins and their function in protein homeostasis","volume":"427","author":"Haslbeck","year":"2015","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.brainres.2025.149568_b0150","first-page":"195","article-title":"Interleukin-1\u03b2 in central nervous system injury and repair","volume":"1","author":"Hewett","year":"2012","journal-title":"Eur. J. Neurodegenerative Dis."},{"key":"10.1016\/j.brainres.2025.149568_b0155","first-page":"2183","article-title":"IL-6 in neuroinflammation and BBB disruption","volume":"11","author":"Hidalgo-Lanussa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2025.149568_b0160","article-title":"Early onset synucleinopathies: differential diagnosis and what not to miss","author":"Ibrahim","year":"2024","journal-title":"Synucleinopath. Relat. Disord."},{"key":"10.1016\/j.brainres.2025.149568_b0165","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/13543780903066780","article-title":"An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer\u2019s disease","volume":"18","author":"Imbimbo","year":"2009","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.brainres.2025.149568_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1376-1","article-title":"Circulating levels of IL-1 family cytokines and receptors in Alzheimer\u2019s disease: new markers of disease progression?","volume":"15","author":"Italiani","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainres.2025.149568_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","article-title":"Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease","volume":"147","author":"Jiang","year":"2016","journal-title":"Prog. Chem. Org. Nat. Prod. Neurobiol."},{"key":"10.1016\/j.brainres.2025.149568_b0180","first-page":"369","article-title":"Cerebrospinal fluid biochemical studies in patients with Parkinson\u2019s disease: toward a potential search for biomarkers for this disease","volume":"8","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2014","journal-title":"Front Cell. Neurosci."},{"key":"10.1016\/j.brainres.2025.149568_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0190","doi-asserted-by":"crossref","first-page":"34830","DOI":"10.1038\/srep34830","article-title":"Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G","volume":"6","author":"Kakkar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2025.149568_b0195","first-page":"27","article-title":"TGF-\u03b2-induced glial scarring in neurodegeneration","volume":"159","author":"Kandasamy","year":"2020","journal-title":"Neurosci. Res."},{"issue":"23","key":"10.1016\/j.brainres.2025.149568_b0200","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.brainres.2025.149568_b0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tcb.2012.05.006","article-title":"Chaperone-mediated autophagy: a unique way to enter the lysosome world","volume":"22","author":"Kaushik","year":"2012","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.brainres.2025.149568_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoisel\u00e9e","year":"2017","journal-title":"PLoS Med."},{"issue":"14","key":"10.1016\/j.brainres.2025.149568_b0215","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1093\/hmg\/dds143","article-title":"\u03b1-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death, and inflammation in early-stage Parkinson\u2019s disease","volume":"21","author":"Lastres-Becker","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.brainres.2025.149568_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson\u2019s disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11011-019-00516-y","article-title":"Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death","volume":"35","author":"Leong","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2025.149568_b0230","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1007\/s12035-020-01934-1","article-title":"Ferulic acid ameliorates MPP+\/MPTP-induced oxidative stress via ERK1\/2-dependent Nrf2 activation: translational implications for Parkinson\u2019s disease treatment","volume":"57","author":"Li","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.brainres.2025.149568_b0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainres.2014.08.040","article-title":"Neuroinflammatory changes negatively impact on LTP: A focus on IL-1\u03b2","volume":"1621","author":"Lynch","year":"2015","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.brainres.2025.149568_b0245","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1039\/C7FO00809K","article-title":"Protective effects of fisetin and other berry flavonoids in Parkinson\u2019s disease","volume":"8","author":"Maher","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.brainres.2025.149568_b0250","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149568_b0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fphar.2014.00147","article-title":"Nutraceuticals in cognitive impairment and Alzheimer\u2019s disease","volume":"5","author":"Mecocci","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149568_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153712","article-title":"Cascade of immune mechanism and consequences of inflammatory disorders","volume":"91","author":"Megha","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11481-011-9287-2","article-title":"Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system","volume":"7","author":"Montgomery","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"10423","key":"10.1016\/j.brainres.2025.149568_b0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0275","first-page":"43","article-title":"Alzheimer\u2019s disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis."},{"issue":"17","key":"10.1016\/j.brainres.2025.149568_b0280","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.febslet.2014.05.046","article-title":"Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis","volume":"588","author":"Neniskyte","year":"2014","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.brainres.2025.149568_b0285","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.2353\/ajpath.2010.100339","article-title":"Transgenic mice overexpressing APP and transforming growth factor-\u03b21 feature cognitive and vascular hallmarks of Alzheimer\u2019s disease","volume":"177","author":"Ongali","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/15376516.2023.2288198","article-title":"Oleanolic acid-based therapeutics ameliorate rotenone-induced motor and depressive behaviors in parkinsonian male mice via controlling neuroinflammation and activating Nrf2-BDNF-dopaminergic signaling pathways","volume":"34","author":"Pingale","year":"2024","journal-title":"Toxicol. Mech. Methods"},{"issue":"6","key":"10.1016\/j.brainres.2025.149568_b0295","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/01616412.2021.2024726","article-title":"Dopaminergic neuronal death in the substantia nigra associates with change in serum levels of TNF-\u03b1 and IL-1\u03b2; evidence from early experimental model of Parkinson\u2019s disease","volume":"44","author":"Piri","year":"2022","journal-title":"Neurol. Res."},{"issue":"21","key":"10.1016\/j.brainres.2025.149568_b0300","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149568_b0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fnagi.2014.00218","article-title":"Neuroprotective effects of resveratrol in Alzheimer\u2019s disease pathology","volume":"6","author":"Rege","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.brainres.2025.149568_b0310","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/jcm8091377","article-title":"DJ-1 in Parkinson\u2019s disease: clinical insights and therapeutic perspectives","volume":"8","author":"Repici","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.brainres.2025.149568_b0315","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/molecules26071844","article-title":"Superoxide dismutase administration: a review of proposed human uses","volume":"26","author":"Rosa","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0320","article-title":"A review: inflammatory process in Alzheimer\u2032 s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"Sci. World J."},{"issue":"22","key":"10.1016\/j.brainres.2025.149568_b0325","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of the Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.brainres.2025.149568_b0330","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0335","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants\u2013past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"23","key":"10.1016\/j.brainres.2025.149568_b0340","doi-asserted-by":"crossref","first-page":"23478","DOI":"10.18632\/aging.202343","article-title":"Transforming growth factor beta type 1 (TGF-\u03b2) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells","volume":"12","author":"Seln\u00f8","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.brainres.2025.149568_b0345","unstructured":"Shafiq, K. (2020). Oxidative modification of SOD1 as a mechanism of pathological aging."},{"key":"10.1016\/j.brainres.2025.149568_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-014-0080-6","article-title":"Immunosuppressive\/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction-a novel mechanism for maintaining vascular function","volume":"7","author":"Shao","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.brainres.2025.149568_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110373","article-title":"Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease","volume":"129","author":"Sharma","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.brainres.2025.149568_b0360","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1007\/s11033-023-08573-4","article-title":"Drug-induced nephrotoxicity mechanistic approach","volume":"50","author":"Sharma","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.brainres.2025.149568_b0365","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s10787-024-01557-1","article-title":"Leukotriene signaling in neurodegeneration: implications for treatment strategies","volume":"32","author":"Sharma","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0370","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s43440-024-00613-5","article-title":"Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases","volume":"76","author":"Sharma","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainres.2025.149568_b0375","first-page":"1","article-title":"Mechanistic insights on the role of Nrf-2 signaling in Huntington\u2019s disease","author":"Sharma","year":"2024","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020670610512","article-title":"Emerging role of Nrf2 in Parkinson\u2019s disease therapy: a critical reassessment","volume":"40","author":"Sharma","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2025.149568_b0385","first-page":"106","article-title":"Mitochondria-targeted antioxidants as therapies","volume":"11","author":"Smith","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.brainres.2025.149568_b0390","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2018.00114","article-title":"Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+T cells in neurodegenerative diseases","volume":"12","author":"Solleiro-Villavicencio","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2025.149568_b0395","first-page":"1036","article-title":"IL-6 suppresses neurotrophic factor signaling","volume":"32","author":"Sterneck","year":"2012","journal-title":"J Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2025.149568_b0400","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pneurobio.2010.05.002","article-title":"Heat shock proteins: cellular and molecular mechanisms in the central nervous system","volume":"92","author":"Stetler","year":"2010","journal-title":"Prog. Chem. Org. Nat. Prod. Neurobiol."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0405","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JAD-215074","article-title":"Dimethyl fumarate is a potential therapeutic option for Alzheimer\u2019s disease","volume":"85","author":"Sun","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.brainres.2025.149568_b0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.ircmb.2015.07.007","article-title":"Intracellular dynamics of synucleins:\u201chere, there and everywhere\u201d","volume":"320","author":"Surguchov","year":"2015","journal-title":"International Review of Cell and Molecular Biology"},{"key":"10.1016\/j.brainres.2025.149568_b0415","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","article-title":"Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer\u2019s disease, Parkinson\u2019s disease","volume":"111","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.brainres.2025.149568_b0420","article-title":"Oleanonic acid ameliorates mutant A\u03b2 precursor protein-induced oxidative stress, autophagy deficits, ferroptosis, mitochondrial damage, and ER stress in vitro","volume":"1870","author":"Tao","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.brainres.2025.149568_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-72","article-title":"Dopamine and \u03b1-synuclein dysfunction in Smad3 null mice","volume":"6","author":"Tapia-Gonz\u00e1lez","year":"2011","journal-title":"Mol. Neurodegeneration"},{"issue":"11","key":"10.1016\/j.brainres.2025.149568_b0430","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.brainres.2025.149568_b0435","doi-asserted-by":"crossref","first-page":"14574","DOI":"10.3390\/ijms232314574","article-title":"IL-6 and IL-8: an overview of their roles in healthy and pathological pregnancies","volume":"23","author":"Viloti\u0107","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.brainres.2025.149568_b0440","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3390\/ijms18122772","article-title":"Nrf2, the master regulator of anti-oxidative responses","volume":"18","author":"Vomund","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149568_b0445","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.brainres.2025.149568_b0450","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1083\/jcb.201708007","article-title":"Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling","volume":"217","author":"Wang","year":"2018","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.brainres.2025.149568_b0455","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/15548627.2016.1179401","article-title":"Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7","volume":"12","author":"Wang","year":"2016","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.brainres.2025.149568_b0460","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.brainres.2025.149568_b0465","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fphar.2019.01047","article-title":"Small heat shock proteins, big impact on protein aggregation in neurodegenerative disease","volume":"10","author":"Webster","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2025.149568_b0470","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1007\/s11064-016-1995-9","article-title":"Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson\u2019s disease","volume":"41","author":"Xu","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2025.149568_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108972","article-title":"Stress level of glucocorticoid exacerbates neuronal damage and A\u03b2 production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice","volume":"110","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2025.149568_b0480","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","article-title":"Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson\u2019s disease: an overview and update on new developments","volume":"50","author":"Zamanian","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.brainres.2025.149568_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117101","article-title":"Pharmacological mechanisms of puerarin in the treatment of Parkinson\u2019s disease: an overview","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0490","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Trans. Target. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0495","doi-asserted-by":"crossref","first-page":"32206","DOI":"10.1038\/srep32206","article-title":"Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.brainres.2025.149568_b0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10715762.2012.742518","article-title":"Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3\u03b2\/Nrf2 signaling pathway","volume":"47","author":"Zou","year":"2013","journal-title":"Free Radic. Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932500126X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932500126X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:15:29Z","timestamp":1791648929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689932500126X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":100,"alternative-id":["S000689932500126X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149568","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149568"}}